South Texas Accelerated Research Therapeutics (Start) - Midwest Location is a clinical research site located in Grand Rapids, Michigan, United States 49546.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
South Texas Accelerated Research Therapeutics (Start) - Midwest Location has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Lymphoma, T-Cell.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
South Texas Accelerated Research Therapeutics (Start) - Midwest Location has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
South Texas Accelerated Research Therapeutics (Start) - Midwest Location has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Lymphoma, T-Cell.
South Texas Accelerated Research Therapeutics (Start) - Midwest Location has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.